Company / Net Income
IRONWOOD PHARMACEUTICALS INC Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$24.0M
FY2025
5-year range
-$1.0B / $528.4M
FY2021-FY2025
Trend
-86.3%
vs FY2024
Sector context
#53 of 216
Health Care
What the data says
IRONWOOD PHARMACEUTICALS INC's net income of $24M is higher than 75% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 10 years, ranging from -$1.0B in FY2023 to $528M in FY2021.
Based on SEC 10-K filings.
$24M in FY2025 with a 3-year CAGR of -39.1%. Top quartile in the Health Care sector.
Improved from -$1.0B to $24M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -39.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 216This company $24.0M Sector average $454.1M
▼
-94.7% below sector average
Key checks
Key Insights
- 3-year CAGR of -39.1%, indicating a declining trend.
- In FY2025, net income decreased 86.3% year-over-year.
- Ranks #53 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.0M | -86.3% |
| FY2024 | $175.1M | +117.5% |
| FY2023 | -$1.0B | -1043.9% |
| FY2022 | $106.2M | -79.9% |
| FY2021 | $528.4M | +287.1% |
| FY2020 | -$282.4M | -1413.0% |
| FY2019 | $21.5M | +126.3% |
| FY2018 | -$81.7M | +30.1% |
| FY2017 | -$116.9M | -43.1% |
| FY2016 | -$81.7M | +42.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026